ACUTE MYELOGENOUS LEUKEMIA
Clinical trials for ACUTE MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer vaccine aims to stop leukemia from coming back
⭐️ VACCINE ⭐️ OngoingThis study tests a personalized vaccine made from a patient's own leukemia cells and immune cells. The goal is to see if the vaccine can help keep acute myeloid leukemia (AML) in remission after chemotherapy. About 82 adults aged 55 and older who are in remission will either rece…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 02:02 UTC
-
New hope for blood cancer patients: using mismatched donors for transplants
Disease control OngoingThis study tests a stem cell transplant using donors who are not a perfect match for people with blood cancers like leukemia or lymphoma. The goal is to see if adding certain drugs after the transplant can prevent complications and improve survival. About 300 adults and children …
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control TerminatedThis study tests an oral medication called emavusertib (CA-4948) in adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has returned or not responded to prior treatments. The goal is to find the safest and most effective dose and to see if th…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New vaccine aims to keep leukemia in check after transplant
Disease control OngoingThis early-phase study tests a custom-made cancer vaccine (DC/AML fusion) for people with acute myeloid leukemia who have recently had a stem cell transplant. The vaccine is designed to train the immune system to recognize and attack remaining leukemia cells. Some participants al…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Scientists seek blood samples to unlock cancer secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from 550 people with blood cancers like leukemia and lymphoma. Researchers will study the samples in the lab to learn more about how these cancers work and find new ways to treat them. Participants only give samples when already n…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 02:14 UTC